Costs Of Overactive Bladder Symptoms Treatment With Solifenacin

Abstract

A509cost of each stage of kidney disease according scheduled visits in each condition, and, therefore, to calculate the economic burden of one year dialysis for the Spanish Health System, to check the advantage of a treatment that could delay the disease progression of ADPKD. Methods: The model was based in normal practice of a specific hospital, selected for it's expertise within ADPKD. To build the model the following figures were provided: Hospital costs (number of expected healthcare provider visits, analytics, image diagnosis), and other expected costs (such ambulance transport and concomitant treatments for hypertension, hypercholesterolemia, hyperuricemia, pain, infections, and haematuria). In addition to this, costs from the patient's perspective, namely medication and transport costs were also analysed. Results: The annual cost for dialysis patients in Hospital La Paz, and Madrid Province, in general, is 56,028 euros (43,980.00 € for Hospital costs, up to 600 € for medication, and 11,448 € for ambulance transport) , while the rest of Chronic Kidney Disease stages (CKD stages 1-4) range annually between 809-1.551 € (Hospital costs and medication). Therefore, avoiding 1 year of dialysis will represent around 54,800 € savings. ADPKD patients cover additional expenses (up to 350 € for medication and 8-195 € for transport, annually). ConClusions: Dialysis extensively increases the economic burden of ADPKD, this is mainly seen in the healthcare system. ADPKD patients are faced with medication costs and travel expenses, as well as other incommodities and non-calculated indirect costs. Therefore, a treatment able to delay the disease progression represents an important step towards patient wellbeing and big savings for the Health System PUK9 Do Socioeconomic ineqUalitieS imPact the Social coSt of chronic KiDney DiSeaSe in italy?